Paul Tudor Jones’s Agilon Health AGL Stock Holding History

Paul Tudor Jones’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.79M	Buy	35,336 +3,106	+10%	+$203K	0.01%	1481
2026 Q1	$255K	Hold	32,230	–	–	﹤0.01%	3235
2025 Q4	$555K	Hold	32,230	–	–	﹤0.01%	2670
2025 Q3	$830K	Sell	32,230 -22,315	-41%	-$843K	﹤0.01%	2390
2025 Q2	$3.14M	Sell	54,545 -6,363	-10%	-$510K	0.01%	1362
2025 Q1	$6.59M	Buy	60,908 +135	+0.2%	+$11.7K	0.02%	664
2024 Q4	$2.89M	Sell	60,773 -506	-0.8%	-$30.6K	0.01%	1003
2024 Q3	$6.02M	Buy	61,279 +11,240	+22%	+$1.45M	0.02%	620
2024 Q2	$8.18M	Buy	50,039 +1,075	+2%	+$153K	0.04%	455
2024 Q1	$7.47M	Buy	48,964 +25,708	+111%	+$4.28M	0.05%	454
2023 Q4	$7.3M	Buy	23,256 +18,183	+358%	+$6.58M	0.06%	462
2023 Q3	$2.25M	Buy	+5,073	New	+$2.29M	0.02%	862
2023 Q2	–	Sell	-2,779	Closed	-$1.65M	–	2378
2023 Q1	$1.65M	Buy	+2,779	New	+$1.56M	0.03%	884
2022 Q4	–	Sell	-1,806	Closed	-$1.06M	–	2318
2022 Q3	$1.06M	Buy	+1,806	New	+$1.08M	0.02%	875

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Paul Tudor Jones's AGL Position: Q2 2026 in Review

Paul Tudor Jones increased its Agilon Health (AGL) stake by 9.6% in Q2 2026, buying an estimated $203K and bringing the position to 35,336 shares worth $3.79M. The position accounts for 0.01% of the portfolio, ranked #1481.

Paul Tudor Jones first reported a position in AGL in Q3 2022 and has held it in 14 quarters since. The position peaked at $8.18M in Q2 2024. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Paul Tudor Jones held 35,336 shares of Agilon Health worth $3.79M as of Q2 2026.
Paul Tudor Jones bought 3,106 Agilon Health shares in Q2 2026, an estimated $203K.
Agilon Health made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1481 holding.
Paul Tudor Jones first reported a position in Agilon Health in Q3 2022 and has held it in 14 quarters since.
Paul Tudor Jones's Agilon Health position peaked at $8.18M in Q2 2024.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.